436 results on '"Ossendorp, Ferry"'
Search Results
2. Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer
3. Therapeutic liposomal combination to enhance chemotherapy response and immune activation of tumor microenvironment
4. Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors
5. Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation
6. OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
7. Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer
8. A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection
9. M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer
10. Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control
11. Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment
12. Quantification of Lipid and Peptide Content in Antigenic Peptide-loaded Liposome Formulations by Reversed-phase UPLC using UV Absorbance and Evaporative Light Scattering Detection
13. Upconversion nanoparticle platform for efficient dendritic cell antigen delivery and simultaneous tracking
14. Thermosensitive hydrogels as sustained drug delivery system for CTLA-4 checkpoint blocking antibodies
15. Photodynamic cancer therapy enhances accumulation of nanoparticles in tumor-associated myeloid cells
16. Cationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responses
17. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences
18. Hollow microneedle-mediated micro-injections of a liposomal HPV E743–63 synthetic long peptide vaccine for efficient induction of cytotoxic and T-helper responses
19. Autoreactive CD8 T Cells Associated with β Cell Destruction in Type 1 Diabetes
20. Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment
21. Reorganization of Multivesicular Bodies Regulates MHC Class II Antigen Presentation by Dendritic Cells
22. Dual‐Targeting Nanoliposome Improves Proinflammatory Immunomodulation of the Tumor Microenvironment.
23. Chapter Two - How B cells drive T-cell responses: A key role for cross-presentation of antibody-targeted antigens.
24. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles
25. Combinatorial prospects of nano-targeted chemoimmunotherapy
26. Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
27. Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation
28. The potential of multi-compound nanoparticles to bypass drug resistance in cancer
29. Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study
30. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice
31. Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancer
32. Linking T cell epitopes to a common linear B cell epitope: A targeting and adjuvant strategy to improve T cell responses
33. Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides
34. TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors
35. Therapeutic cancer vaccines
36. MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression.
37. Current Challenges and Opportunities of Photodynamic Therapy against Cancer.
38. Cationic Liposomes Loaded with a Synthetic Long Peptide and Poly(I:C): a Defined Adjuvanted Vaccine for Induction of Antigen-Specific T Cell Cytotoxicity
39. Antigen Storage Compartments in Mature Dendritic Cells Facilitate Prolonged Cytotoxic T Lymphocyte Cross-Priming Capacity
40. Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment.
41. Differential and sustained cross-presentation by DC subsets in vivo
42. The Translocon Protein Sec61 Mediates Antigen Transport from Endosomes in the Cytosol for Cross-Presentation to CD8+ T Cells
43. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells
44. Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire
45. Efficient ex vivo induction of T cells with potent anti-tumor activity by protein antigen encapsulated in nanoparticles
46. Bacterial Cellulose as Drug Delivery System for Optimizing Release of Immune Checkpoint Blocking Antibodies.
47. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants
48. Autoreactive CD8 T cells associated with [beta] cell destruction in type 1 diabetes
49. Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8 + T cells in vivo
50. Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.